Article Information
History
- December 7, 2021.
Article Versions
- Version 1 (September 23, 2021 - 03:37).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Sandile Cele1,2,
- Farina Karim1,2,
- Gila Lustig3,
- James Emmanuel San4,
- Tandile Hermanus5,6,
- Houriiyah Tegally4,
- Jumari Snyman1,7,
- Thandeka Moyo-Gwete,
- Eduan Wilkinson4,8,
- Mallory Bernstein1,
- Khadija Khan1,2,
- Shi-Hsia Hwa1,9,
- Sasha W. Tilles10,
- Lavanya Singh4,
- Jennifer Giandhari4,
- Ntombifuthi Mthabela1,
- Matilda Mazibuko1,
- Yashica Ganga1,
- Bernadett I. Gosnell11,
- Salim Abdool Karim3,
- Willem Hanekom1,9,
- Wesley C. Van Voorhis10,
- Thumbi Ndung’u1,7,
- COMMIT-KZN Team§,
- Richard J. Lessells2,3,4,
- Penny L. Moore3,5,6,
- Mahomed-Yunus S. Moosa11,
- Tulio de Oliveira2,3,4,8,12 and
- Alex Sigal1,2,13,*
- 1Africa Health Research Institute, Durban, South Africa
- 2School of Laboratory Medicine and Medical Sciences, University of KwaZulu-Natal, Durban, South Africa
- 3Centre for the AIDS Programme of Research in South Africa, Durban, South Africa
- 4KwaZulu-Natal Research Innovation and Sequencing Platform, Durban, South Africa
- 5National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa
- 6MRC Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
- 7Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
- 8HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa
- 9Division of Infection and Immunity, University College London, London, UK
- 10Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, USA
- 11Department of Infectious Diseases, Nelson R. Mandela School of Clinical Medicine, University of KwaZulu-Natal, Durban, South Africa
- 12Department of Global Health, University of Washington, Seattle, USA
- 13Max Planck Institute for Infection Biology, Berlin, Germany
- ↵*Corresponding author. Email: alex.sigal{at}ahri.org
Posted December 07, 2021.
SARS-CoV-2 evolved during advanced HIV disease immunosuppression has Beta-like escape of vaccine and Delta infection elicited immunity
